Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-09

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for oxybutynin chloride submitted by Chartwell RX, LLC. The approval confirms continuation of the generic product's use …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)